title: [Treatment modalities of hydatid cysts of the liver: progress or revolution?].
authors.affiliation: Service d'Hépato-Gastro-Entérologie, Hôpital d'Instruction des Armées Laveran, Marseille-Armées, France.
authors.forename: J M
authors.initials: JM
authors.lastname: Debonne
authors.forename: P
authors.initials: P
authors.lastname: Legall
authors.forename: P
authors.initials: P
authors.lastname: Rey
authors.forename: T
authors.initials: T
authors.lastname: Coton
authors.forename: D
authors.initials: D
authors.lastname: Carre
authors.forename: M
authors.initials: M
authors.lastname: Guisset
authors.forename: F
authors.initials: F
authors.lastname: Klotz
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015766:Albendazole / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D000871:Anthelmintics / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D000969:Antinematodal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D002648:Child; D004351:Drug Resistance; D004444:Echinococcosis, Hepatic / Q000188:drug therapy*; D000431:Ethanol / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005544:Forecasting; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008463:Mebendazole / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D008875:Middle Aged; D019152:Paracentesis / Q000379:methods; D011159:Population Surveillance; D012008:Recurrence; D013997:Time Factors; D018084:Ultrasonography, Interventional
chemical_list: D000871:Anthelmintics; D000969:Antinematodal Agents; D000431:Ethanol; D008463:Mebendazole; D015766:Albendazole
vernacular_title: Modalites therapeutiques du kyste hydatique du foie: avancée ou révolution?